Close

Professor Chris Drakeley

PhD

Professor
of Infection & Immunity

Room
238b

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
020 7927 2289

Chris Drakeley is a Professor of Infection & Immunity at the London School of Hygiene & Tropical Medicine. He has more than 30 years experience of working on malaria with much of his time spent working overseas in a variety of African countries including Tanzania & The Gambia. His research centres on developing a better understanding of malaria transmission of parasites in different settings. This includes studies aimed at understanding the fundamentals of malaria transmission dynamics including risks factors for transmission in endemic populations and defining the infectious reservoir of malaria. His group is involved in the comparison and optimisation of approaches to measure transmission with a focus on serological markers for exposure to infection. These components are linked together by the evaluation of strategies designed to reduce and block transmission including transmission blocking vaccines and drugs.

Affiliations

Department of Infection Biology
Faculty of Infectious and Tropical Diseases

Centres

Malaria Centre
Vaccine Centre

Research

Research Area
Diagnostics
Infectious disease policy
Surveillance
Disease control
Protozoa
Spatial analysis
Discipline
Immunoepidemiology
Epidemiology
Immunology
Parasitology
Disease and Health Conditions
Malaria
Emerging Infectious Disease
Neglected Tropical Diseases (NTDs)
Zoonotic disease
Country
Burkina Faso
Botswana
Cape Verde
Dominican Republic
Ethiopia
United Kingdom
Ghana
The Gambia
Equatorial Guinea
Haiti
Cambodia
Myanmar (Burma)
Mozambique
Philippines
Sierra Leone
Uganda
United States of America
South Africa
Region
Caribbean small states
East Asia & Pacific (developing only)
Latin America & Caribbean (all income levels)
Middle East & North Africa (developing only)
Pacific island small states
Sub-Saharan Africa (all income levels)

Selected Publications

A framework for evaluating health system surveillance sensitivity to support public health decision-making for malaria elimination: a case study from Indonesia.
Ahmad RA; Nelli L; Surendra H; Arisanti RR; Lesmanawati DAS; Byrne I; Dumont E; Drakeley C; Stresman G; Wu L
2022
BMC infectious diseases
Multiplex Serology for Measurement of IgG Antibodies Against Eleven Infectious Diseases in a National Serosurvey: Haiti 2014-2015.
Chan Y; Martin D; Mace KE; Jean SE; Stresman G; Drakeley C; Chang MA; Lemoine JF; Udhayakumar V; Lammie PJ
2022
Frontiers in Public Health
The acquisition of humoral immune responses targeting Plasmodium falciparum sexual stages in controlled human malaria infections.
de Jong RM; Alkema M; Oulton T; Dumont E; Teelen K; Nakajima R; de Assis RR; Press KWD; Ngotho P; Tetteh KKA
2022
Frontiers in immunology
Etramp5 as a useful serological marker in children to assess the immediate effects of mass drug campaigns for malaria.
Druetz T; van den Hoogen L; Stresman G; Joseph V; Hamre KES; Fayette C; Monestime F; Presume J; Romilus I; Mondélus G
2022
BMC infectious diseases
Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi.
Longley RJ; Grigg MJ; Schoffer K; Obadia T; Hyslop S; Piera KA; Nekkab N; Mazhari R; Takashima E; Tsuboi T
2022
Cell Reports Medicine
Estimating female malaria mosquito age by quantifying Y-linked genes in stored male spermatozoa.
Madan D; Rivera R; Ortega C; Touchon JC; Kimball C; van Gemert G-J; Graumans W; Matsuura S; Parghi SS; Bell D
2022
Scientific Reports
Antibody dynamics in children with first or repeat Plasmodium falciparum infections
Rogier E; Nace D; Dimbu PR; Wakeman B; Beeson JG; Drakeley C; Tetteh K; Plucinski M
2022
Frontiers in Medicine
See more Publications